In a study published in the journal Nature Communications, Gino Cingolani, Ph.D., of the University of Alabama at Birmingham, and Federica Briani, Ph.D., of the Università degli Studi di Milano, Milan ...

But in this case, a phage molecule is secreted by the bacteria themselves, and it has a symbiotic relationship with Pseudomonas aeruginosa. In fact, it forms these liquid crystalline droplets ...

DEV infects and lyses Pseudomonas aeruginosa bacteria, an opportunistic pathogen in cystic fibrosis and other diseases. DEV ...

Synthetic biology techniques have emerged as transformative tools in the tug-of-war between humans and drug-resistant ...

DEV infects and lyses Pseudomonas aeruginosa bacteria, an opportunistic pathogen in cystic fibrosis and other diseases. DEV ...

a top candidate for inclusion into Armata's multi-phage anti-Pseudomonas clinical products LOS ANGELES, Oct. 30, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP ...

PHAXIAM’s phagogram represents a robust solution to guide physicians in selecting phage-based treatments. It also plays a critical role in monitoring antimicrobial resistance (AMR), as the first ...

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company ...